LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 11.56 | 771.67 | 1230 | 1280 | 0.9605 | 0.8926 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 11.56 | 771.67 | 1213 | 1280 | 0.9472 | 0.8569 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 13.78 | 771.67 | 1359 | 1459 | 0.9310 | 0.8504 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 13.78 | 771.67 | 1321 | 1459 | 0.9050 | 0.7942 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 16.00 | 771.67 | 1444 | 1585 | 0.9108 | 0.8279 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 16.00 | 771.67 | 1400 | 1585 | 0.8830 | 0.7743 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 18.22 | 771.67 | 1505 | 1741 | 0.8643 | 0.7663 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 18.22 | 771.67 | 1420 | 1741 | 0.8155 | 0.6810 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.44 | 771.67 | 1551 | 1910 | 0.8117 | 0.7051 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.44 | 771.67 | 1437 | 1910 | 0.7520 | 0.6085 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.66 | 771.67 | 1523 | 2141 | 0.7112 | 0.5868 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.66 | 771.67 | 1430 | 2141 | 0.6678 | 0.5203 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.89 | 771.67 | 1527 | 2397 | 0.6369 | 0.5178 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.89 | 771.67 | 1457 | 2397 | 0.6077 | 0.4749 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 27.11 | 771.67 | 1554 | 2675 | 0.5809 | 0.4774 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 27.11 | 771.67 | 1425 | 2675 | 0.5327 | 0.4077 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 29.33 | 771.67 | 1511 | 2939 | 0.5141 | 0.4166 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 29.33 | 771.67 | 1471 | 2939 | 0.5005 | 0.3971 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 31.55 | 771.67 | 1534 | 3196 | 0.4799 | 0.3980 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 31.55 | 771.67 | 1429 | 3196 | 0.4470 | 0.3505 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 33.78 | 771.67 | 1555 | 3499 | 0.4443 | 0.3788 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 33.78 | 771.67 | 1457 | 3499 | 0.4163 | 0.3383 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.00 | 771.67 | 1557 | 3884 | 0.4008 | 0.3513 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.00 | 771.67 | 1504 | 3884 | 0.3872 | 0.3314 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.22 | 771.67 | 1603 | 4299 | 0.3728 | 0.3431 | MN20160304_L01 | D08 |